Skip to main content
Clinical Trials/NCT05853978
NCT05853978
Completed
Phase 4

The Evaluation of Balanced Salt Solution During Cataract Surgery

Adam Fedyk, MD, FACS1 site in 1 country26 target enrollmentStarted: April 17, 2023Last updated:

Overview

Phase
Phase 4
Status
Completed
Sponsor
Adam Fedyk, MD, FACS
Enrollment
26
Locations
1
Primary Endpoint
Central Corneal Thickness (CCT)

Overview

Brief Summary

This study aims to identify if the use of BSS PLUS® Sterile Intraocular Irrigating Solution as an irrigation solution leads to improved corneal outcomes vs BSS® Sterile Irrigating Solution in more compromised corneas.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
22 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

BSS Plus

Experimental

Intervention: BSS Plus (Drug)

BSS

Active Comparator

Intervention: BSS (Drug)

Outcomes

Primary Outcomes

Central Corneal Thickness (CCT)

Time Frame: Postoperative: Day 1

Changes in central corneal thickness following cataract surgery with BSS PLUS® Sterile Intraocular Irrigating Solution, as compared to BSS® Sterile Irrigating Solution

Secondary Outcomes

  • Intraoperative Grading of Corneal Edema(Day 0)
  • Number of Intraocular Irrigating Solution Drops Used(Day 0)

Investigators

Sponsor
Adam Fedyk, MD, FACS
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Adam Fedyk, MD, FACS

Owner

St. Louis Eye Institute

Study Sites (1)

Loading locations...

Similar Trials